Randall Moreadith, Chief Scientific Officer at Serina Therapeutics, Inc. (SER), sold 6,500 shares at $0.04 ($232) on 2026-01-28, disclosed to the SEC on 2026-01-29.
Open-market sale of $232 SER by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SER | SELL | 2026-02-03 | $20K | — | Filing → |
| SER | SELL | 2026-01-23 | $7K | — | Filing → |
| SER | SELL | 2026-01-21 | $12K | — | Filing → |